Your browser doesn't support javascript.
loading
SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease.
D'Silva, Kristin M; Serling-Boyd, Naomi; Hsu, Tiffany Y-T; Sparks, Jeffrey A; Wallace, Zachary S.
Affiliation
  • D'Silva KM; Rheumatology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Serling-Boyd N; Rheumatology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Hsu TY; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Sparks JA; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Wallace ZS; Rheumatology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA zswallace@partners.org.
Ann Rheum Dis ; 80(6): 817-819, 2021 06.
Article in En | MEDLINE | ID: mdl-33436385
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Rheumatic Diseases / Antirheumatic Agents / COVID-19 Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Rheumatic Diseases / Antirheumatic Agents / COVID-19 Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2021 Type: Article Affiliation country: United States